Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

15.45 USD -0.05 (-0.33%)
Streaming Delayed Price Updated: 1:20 PM EDT, Aug 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 234,952
Open 15.80
Bid (Size) 15.44 (10)
Ask (Size) 15.50 (47)
Prev. Close 15.50
Today's Range 15.26 - 16.04
52wk Range 14.42 - 22.91
Shares Outstanding N/A
Dividend Yield 38.84%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health th
From GlobeNewswire News Releases
Psychedelics -- Not Just for Mental Health Anymore
NetworkNewsWire Editorial Coverage 
From PR Newswire

Performance

YTD
-20.57%
-20.57%
1 Month
-14.32%
-14.32%
3 Month
-20.57%
-20.57%
6 Month
-20.57%
-20.57%
1 Year
-20.57%
-20.57%

More News

Read More
NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Breaks New Ground in Psilocybin Space
From InvestorBrandNetwork
Leading U.S.-Based Psychedelic Healthcare VC Fund Launches with $35 Million Raised to Tackle the Growing Global Mental Health Crisis
From PR Newswire
Psychedelics — Not Just for Mental Health Anymore
From InvestorBrandNetwork
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
Tags ENTBF FTRP Market News
From Benzinga
Psychedelic Decriminalization Creating Market Opportunities
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Psychedelic Decriminalization Creating Market Opportunities
From PR Newswire
Atai Launches New "Nose-To-Brain" Drug Delivery Company To Interact With Its Portfolio Of Psychedelics Subsidiaries
Tags ATAI psychedelics InnarisBio Inc/
From Benzinga
Another Psychedelic Stock Debuts, As This One Sets Up In A Base
From Investor's Business Daily
Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance"
Tags MNMD Small Cap Cannabis
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.